Apotex CEO says IPO provides greater growth potential, despite more scrutiny

Apotex workers are shown in Toronto on Friday, April 9, 2021. THE CANADIAN PRESS/Nathan Denette

TORONTO - Apotex Health Corp.'s CEO says the generic drug maker expects to have more opportunities for growth as a public company, even though being publicly traded can come with more pressure.聽

"There is absolutely a different level of scrutiny as you enter the public markets, and a different level of governance and transparency. I think the organization prepared itself exceptionally well," Jeff Watson said in an interview.聽

The 好色tv Press